丙烯酰胺
- 中文名称：
- 丙烯酰胺
- 中文别名：
- 丙烯酰胺;
2-丙烯酰胺;
丙烯酸酰胺
- 英文名称：
- Acrylamide
- 英文别名：
- acrylamide;
Akrylamid;
optimum;
PROPENAMIDE;
vinylamide;
acrylagel;
Acrylamid;
CH2CHCONH2;
2-propenamide;
carbamoylethylene;
Acrylamide;
ethyleneamide;
vinylcarboxamide;
aam;
acrylic amide
- CAS No.：
- 79-06-1
- 分 子 式：
-
C3H5NO
- 分 子 量：
- 71.08
- 精确分子量：
- 71.03710
- PSA：
- 43.09000
- MDL：
- MFCD00008032
- EINECS：
- 201-173-7
- BRN：
- 605349
- InChI：
- InChI=1/C3H5NO/c1-2-3(4)5/h2H,1H2,(H2,4,5)3
- 危险品标志：
-
T
- 分子结构式：
-
- SDS：
- 查看
丙烯酰胺 制备方法及用途
制备方法
-
1.丙烯腈硫酸水合法:丙烯腈和水在硫酸存在下水解成丙烯酰胺硫酸盐,然后用液氨中和生成丙烯酰胺溶液和硫酸铵,反应物经分离过滤后,将滤液结晶、干燥即得成品。此法的缺点是副产大量价值低廉的硫酸铵,又存在严重的硫酸腐蚀和污染等问题。每吨丙烯酰胺副产硫酸铵2280kg。原料消耗定额:丙烯腈(100%)980kg/t、硫酸(100%)200kg/t、氨(100%)700kg/t。 2.丙烯腈直接水合法:丙烯腈与水在铜催化剂存在下,在85-125℃和0.3-0.4MPa压力下直接水合而得。该法得到的丙烯酰胺水溶液(只含少量副产物),可直接作为产品销售,避免丙烯酰胺粉尘污染,用水溶液对劳动保护是有利的。产品参考规格:外观为白色鳞片状或粉状。一级品含量≥95%;二级品含量≥90%;三级品含量≥85%。 3.酶催化法:在室温下将丙烯腈水溶液送入装有菌种催化剂的固定床反应器中,经反应丙烯腈100%转化为丙烯酰胺。经分离,甚至可不经精制、浓缩就得到丙烯酰胺的工业产品。
合成制备方法
1.丙烯腈硫酸水合法：丙烯腈和水在硫酸存在下水解成丙烯酰胺硫酸盐，然后用液氨中和生成丙烯酰胺溶液和硫酸铵，反应物经分离过滤后，将滤液结晶、干燥即得成品。此法的缺点是副产大量价值低廉的硫酸铵，又存在严重的硫酸腐蚀和污染等问题。每吨丙烯酰胺副产硫酸铵2280kg。原料消耗定额：丙烯腈（100%）980kg/t、硫酸（100%）200kg/t、氨（100%）700kg/t。
2.丙烯腈直接水合法：丙烯腈与水在铜催化剂存在下，在85-125℃和0.3-0.4MPa压力下直接水合而得。该法得到的丙烯酰胺水溶液（只含少量副产物），可直接作为产品销售，避免丙烯酰胺粉尘污染，用水溶液对劳动保护是有利的。产品参考规格：外观为白色鳞片状或粉状。一级品含量≥95%；二级品含量≥90%；三级品含量≥85%。
3.酶催化法：在室温下将丙烯腈水溶液送入装有菌种催化剂的固定床反应器中，经反应丙烯腈100%转化为丙烯酰胺。经分离，甚至可不经精制、浓缩就得到丙烯酰胺的工业产品。
用途简介
-
制备聚丙烯酰胺凝胶，供电泳测定蛋白质分子量等。絮凝剂,土壤稳定剂，增强纸张强度，改进纤维质量，粘结剂。
用途
1.制备聚丙烯酰胺凝胶，供电泳测定蛋白质分子量等。絮凝剂。增强纸张强度。改进纤维质量。粘结剂。
2.丙烯酰胺是丙烯酰胺系和甲基丙烯酰胺系产品中最重要的产品。自1954年用于工业后，需要逐步增长。主要用来制取能溶于水的聚合物，而这种聚丙烯酰胺可作为添加剂用以提高石油的回收率；用作絮凝剂、增厚剂和造纸助剂。少量丙烯酰胺被用来将亲水中心引入亲油的聚合物中以改善粘度，提高软化点和提高树脂的抗溶剂性，并且可以为染料的受色性引入一个中心。丙烯酰胺还常常被用作感光聚合物的一个组分。在乙烯基聚合物中，在交联反应中可以使用这种酰胺基的反应活性。丙烯酰胺可以与某些单体，如乙酸乙烯、苯乙烯、氯乙烯、乙烯叉二氯、丙烯腈等共聚获得具有多种用途的聚合物。主要应用领域：(1)油田用 该品用于油田注水井调整吸水剖面。将本品与引发剂、除氧剂等混合，注入注水井高渗透层带。在地层下聚合成高粘度的聚合物。封堵大孔道，增加扫油体积，提高采油率。此外，本品的聚合物或共聚物，可用于三次采油、压裂、堵水、钻井混浆处理以及化学灌浆等。(2)作絮凝剂 该品的部分水解物或与甲基纤维素的接枝共聚物，用于工厂废水处理及下水处理。(3)土壤改良剂 利用该品水解物作土壤改良剂，可使土壤团粒化，改善空气流通性、水渗透性和保水性。(4)纤维改性与树脂加工 将丙烯酰胺进行氨基甲酰化或接枝聚合。可用于改善含合成纤维的各种纤维的树脂整理，经纱以及作印染浆料使用，以改善纤维织物的基础物性，防皱、防缩和手感好。(5)纸力增强剂 丙烯酰胺与丙烯酸的共聚物或聚丙烯酰胺的部分水解物，可用作纸力培强剂，代替已经使用的淀粉、水溶性氨基树脂或者共用。(6)胶粘剂 有聚丙烯酰胺与酚醛树脂溶液并用的玻璃纤维胶粘剂，以及与合成橡胶并用的压敏胶。
3.核酸分子量的测定。染料合成。塑胶合成。胶粘剂。制备聚丙烯酰胺凝胶，供电泳测定蛋白质分子量。
4.合成纤维工业和合成材料工业的重要原料之一，单体和他的均聚物、共聚物都越来越广泛地被用在国防建设、石油化工、选矿、造纸、纺织和水处理等方面。
5.用于生产絮凝剂、分散剂、添加剂和水溶性聚合物等。[29]
丙烯酰胺 物化性质
- 外观与性状：
- 白色晶体
- 密度：
- 1,322 g/cm3
- 熔点：
- 82-86 °C(lit.)
- 沸点：
- 125 °C25 mm Hg(lit.)
- 闪点：
- 138 °C
- 水溶解性：
- SOLUBLE, 216 g/100 mL
- 折射率：
- 1.460
- 蒸汽密度：
- 2.45 (vs air)
- 存储条件/存储方法：
- 库房通风低温干燥,与氧化剂、酸类、食品化工添加剂分开存放
- 稳定性相关：
1.室温下稳定，但熔融时则骤然聚合。易燃，受高热分解放出腐蚀性气体。受紫外线照射或达熔点温度时很容易聚合同时放热，也可与其他丙烯酸酯、苯乙烯信卤代乙烯等进行共聚。能进行加成、还原、水解等反应。与硫酸反应生成盐。与甲醛反应生成N-羟甲基丙烯酰胺，在酸性催化剂存在下，水解生成丙烯酸。疑为致癌物，毒性较大。丙烯酰胺中有酰氨基和双键两个反应中心。在酸或碱催化剂作用下很容易水解，分别生成丙烯酸盐和丙烯酸。双键可以发生加成反应及聚合反应。安全处理的要求是避免人体与丙烯酰胺接触，防止皮肤对其粉尘或蒸气的吸收。
2.本品剧毒。其蒸气可经呼吸道吸入或经皮肤吸收而引起中毒。主要对中枢神经系统有危害。对眼、皮肤亦有强烈的刺激作用。对家兔LD50为126mg/kg。空气中最高允许浓度0.3mg/m3。生产装置应密闭，厂房要有良好的通风条件，操作人员要穿戴好防护用品。
3.容易通过皮肤和黏膜被人体吸收和累积，引起神经系统的症状，皮肤出现红斑、脱皮；呕吐，腹痛。中毒者肌动电流图和脑电图异常。工作场所空气中有毒物质时间加权平均容许浓度为0.3mg/m3;短时间接触容许浓度为0.9mg/m3。
4.稳定性[24] 稳定
5.禁配物[25] 强氧化剂、酸类、碱类
6.避免接触的条件[26] 受热、光照
7.聚合危害[27] 聚合
- 其它信息：
1.性状：白色或淡黄色结晶，无气味。[1]
2.pH值：5.0~6.5（50%水溶液）[2]
3.熔点（℃）：84.5[3]
4.沸点（℃）：125（3.33kPa）；192.6[4]
5.相对密度（水=1）：1.12[5]
6.相对蒸气密度（空气=1）：2.45[6]
7.饱和蒸气压（kPa）：0.21（84.5℃）[7]
8.临界压力（MPa）：5.73[8]
9.辛醇/水分配系数：-0.67[9]
10.闪点（℃）：138（CC）[10]
11.引燃温度（℃）：424[11]
12.爆炸上限（%）：20.6[12]
13.爆炸下限（%）：2.7[13]
14.溶解性：溶于水、乙醇、乙醚、丙酮，不溶于苯、己烷。[14]
丙烯酰胺 安全信息
- 包装等级：
- III
- 风险类别：
- 6.1
- 海关代码：
- 2924199040
- WGK_Germany：
- 3
德国有关水污染物质的分类清单 - 危险类别码：
- R22;R43;R45;R46;R48/20/21/22
- 安全说明：
- S53-S45-S24-S36/37/39-S26-S36/37
- RTECS号：
- AS3325000
- 安全标志：
- S24:避免接触皮肤。
S26:万一接触眼睛，立即使用大量清水冲洗并送医诊治。
S45:出现意外或者感到不适，立刻到医生那里寻求帮助（最好带去产品容器标签）。
S53:避免暴露——使用前先阅读专门的说明。
:
: - 危险标志：
- T:Toxic
丙烯酰胺 毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- AS3325000
- CHEMICAL NAME :
- Acrylamide
- CAS REGISTRY NUMBER :
- 79-06-1
- BEILSTEIN REFERENCE NO. :
- 0605349
- LAST UPDATED :
- 199712
- DATA ITEMS CITED :
- 140
- MOLECULAR FORMULA :
- C3-H5-N-O
- MOLECULAR WEIGHT :
- 71.09
- WISWESSER LINE NOTATION :
- ZV1U1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- Rinsed with water
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 124 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 400 mg/kg
- TOXIC EFFECTS :
- Blood - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - peptidases
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 90 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 208 mg/kg
- TOXIC EFFECTS :
- Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Behavioral - changes in motor activity (specific assay)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 107 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 170 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 156 mg/kg
- TOXIC EFFECTS :
- Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Behavioral - changes in motor activity (specific assay)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 150 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 1680 uL/kg
- TOXIC EFFECTS :
- Behavioral - hallucinations, distorted perceptions
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 280 mg/kg
- TOXIC EFFECTS :
- Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Behavioral - changes in motor activity (specific assay)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 150 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 170 mg/kg
- TOXIC EFFECTS :
- Behavioral - tremor Behavioral - muscle contraction or spasticity Gastrointestinal - nausea or vomiting
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 173 mg/kg
- TOXIC EFFECTS :
- Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Behavioral - changes in motor activity (specific assay)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - quail
- DOSE/DURATION :
- 186 mg/kg
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - altered sleep time (including change in righting reflex) Behavioral - changes in motor activity (specific assay)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - species unspecified
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - species unspecified
- DOSE/DURATION :
- 190 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1035 mg/kg/15W-I
- TOXIC EFFECTS :
- Behavioral - muscle weakness Behavioral - ataxia Nutritional and Gross Metabolic - weight loss or decreased weight gain
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 608 mg/kg/16D-C
- TOXIC EFFECTS :
- Spinal Cord - other degenerative changes Nutritional and Gross Metabolic - weight loss or decreased weight gain
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1800 mg/kg/90D-C
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - structural change in nerve or sheath Behavioral - fluid intake Nutritional and Gross Metabolic - weight loss or decreased weight gain
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 600 mg/kg/6W-C
- TOXIC EFFECTS :
- Behavioral - changes in motor activity (specific assay) Behavioral - ataxia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 286 mg/kg/28D-C
- TOXIC EFFECTS :
- Brain and Coverings - changes in brain weight Cardiac - changes in heart weight Blood - pigmented or nucleated red blood cells
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 108 mg/kg/3W-I
- TOXIC EFFECTS :
- Brain and Coverings - other degenerative changes Spinal Cord - other degenerative changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - multiple enzyme effects
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 168 mg/kg/2W-C
- TOXIC EFFECTS :
- Behavioral - muscle weakness
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 780 mg/kg/13W-I
- TOXIC EFFECTS :
- Spinal Cord - demyelination Peripheral Nerve and Sensation - structural change in nerve or sheath Behavioral - ataxia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 400 mg/kg/8D-I
- TOXIC EFFECTS :
- Brain and Coverings - other degenerative changes Spinal Cord - other degenerative changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other transferases
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1155 mg/kg/13W-I
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - sensory change involving peripheral nerve Peripheral Nerve and Sensation - recording from peripheral motor nerve Nutritional and Gross Metabolic - weight loss or decreased weight gain
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1 gm/kg/8W-I
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - spastic paralysis with or without sensory change Peripheral Nerve and Sensation - structural change in nerve or sheath
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 568 mg/kg/8W-I
- TOXIC EFFECTS :
- Related to Chronic Data - changes in testicular weight
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1200 mg/kg/4W-I
- TOXIC EFFECTS :
- Behavioral - muscle weakness Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 330 mg/kg/22D-I
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - recording from peripheral motor nerve Behavioral - muscle weakness Behavioral - ataxia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 671 mg/kg/75W-I
- TOXIC EFFECTS :
- Autonomic Nervous System - other (direct) parasympathomimetic Behavioral - changes in motor activity (specific assay) Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 450 mg/kg/61D-I
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - sensory change involving peripheral nerve
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 200 mg/kg/2D-I
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - chronic pulmonary edema Liver - fatty liver degeneration Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 200 mg/kg/4D-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 771 mg/kg/1Y-I
- TOXIC EFFECTS :
- Behavioral - muscle weakness
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 150 mg/kg/10D-I
- TOXIC EFFECTS :
- Brain and Coverings - other degenerative changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - dehydrogenases Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intramuscular
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 300 mg/kg/10D-I
- TOXIC EFFECTS :
- Spinal Cord - other degenerative changes Behavioral - muscle weakness
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - chicken
- DOSE/DURATION :
- 450 mg/kg/3W-I
- TOXIC EFFECTS :
- Behavioral - muscle weakness Behavioral - ataxia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1456 mg/kg/2Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - testicular tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 24 mg/kg/8W-I
- TOXIC EFFECTS :
- Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 300 mg/kg/2W-I
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Lungs, Thorax, or Respiration - tumors Skin and Appendages - tumors
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 72 mg/kg/8W-I
- TOXIC EFFECTS :
- Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1456 mg/kg/2Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - uterine tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- female 7-16 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - biochemical and metabolic
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 560 mg/kg
- SEX/DURATION :
- female 6-21 day(s) after conception lactating female 10 day(s) post-birth
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - parturition Reproductive - Effects on Newborn - stillbirth Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 75 mg/kg
- SEX/DURATION :
- male 5 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 140 mg/kg
- SEX/DURATION :
- female 2 week(s) pre-mating - 3 week(s) post-birth
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 150 mg/kg
- SEX/DURATION :
- male 5 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 350 mg/kg
- SEX/DURATION :
- male 7 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 400 mg/kg
- SEX/DURATION :
- male 8 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Newborn - behavioral
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 571 mg/kg
- SEX/DURATION :
- male 16 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - testes, epididymis, sperm duct
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 95 gm/kg
- SEX/DURATION :
- male 4 week(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 95 gm/kg
- SEX/DURATION :
- female 4 week(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 71 gm/kg
- SEX/DURATION :
- male 4 week(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 225 mg/kg
- SEX/DURATION :
- female 10-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 125 mg/kg
- SEX/DURATION :
- female 1 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 250 mg/kg
- SEX/DURATION :
- male 5 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 300 mg/kg
- SEX/DURATION :
- female 8-10 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 75 mg/kg
- SEX/DURATION :
- female 12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 225 mg/kg
- SEX/DURATION :
- female 10-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death
- TYPE OF TEST :
- Specific locus test
- TYPE OF TEST :
- Micronucleus test
- TYPE OF TEST :
- Unscheduled DNA synthesis
- TYPE OF TEST :
- Sister chromatid exchange
- TYPE OF TEST :
- Dominant lethal test
- TYPE OF TEST :
- Micronucleus test
- TYPE OF TEST :
- Specific locus test
- TYPE OF TEST :
- DNA damage
- TYPE OF TEST :
- Unscheduled DNA synthesis
- TYPE OF TEST :
- Cytogenetic analysis
- TYPE OF TEST :
- Cytogenetic analysis
- TYPE OF TEST :
- Sister chromatid exchange
- TYPE OF TEST :
- Sex chromosome loss and nondisjunction
- TYPE OF TEST :
- Dominant lethal test
- TYPE OF TEST :
- Dominant lethal test
- TYPE OF TEST :
- Sperm Morphology
- TYPE OF TEST :
- Sperm Morphology
- TYPE OF TEST :
- Heritable translocation test
MUTATION DATA
- TYPE OF TEST :
- Sex chromosome loss and nondisjunction
- TEST SYSTEM :
- Rodent - hamster Lung
- REFERENCE :
- MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 245,191,1990 *** REVIEWS *** ACGIH TLV-Animal carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 0.03 mg/m3 (skin) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 39,41,1986 IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 60,389,1994 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 39,41,1986 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 60,389,1994 IARC Cancer Review:Group 2A IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 60,389,1994 TOXICOLOGY REVIEW EVHPAZ EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- Volume(issue)/page/year: 11,129,1975 TOXICOLOGY REVIEW CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year: 2,365,1973 TOXICOLOGY REVIEW CMTVAS Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- Volume(issue)/page/year: 10(3),49,1973 TOXICOLOGY REVIEW CJNSA2 Canadian Journal of Neurological Sciences. (Faculty of Medicine, 2500 University Dr., Calgary, Alberta, Canada) V.1- 1974- Volume(issue)/page/year: 1,143,1974 TOXICOLOGY REVIEW CJNSA2 Canadian Journal of Neurological Sciences. (Faculty of Medicine, 2500 University Dr., Calgary, Alberta, Canada) V.1- 1974- Volume(issue)/page/year: 1,152,1974 TOXICOLOGY REVIEW NTOTDY Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. Volume(issue)/page/year: 3,445,1981 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 0.3 mg/m3 (skin) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,5,1971 OSHA PEL (Gen Indu):8H TWA 0.3 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 0.3 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 0.3 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 0.3 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 0.3 mg/m3;Skin;Carcinogen JAN 1993 OEL-BELGIUM:TWA 0.3 mg/m3;Skin;Carcinogen JAN 1993 OEL-DENMARK:TWA 0.3 mg/m3;Skin;Carcinogen JAN 1993 OEL-FINLAND:TWA 0.3 mg/m3;STEL 0.9 mg/m3 JAN 1993 OEL-FRANCE:TWA 0.3 mg/m3 JAN 1993 OEL-GERMANY;Skin;Carcinogen JAN 1993 OEL-HUNGARY:STEL 0.3 mg/m3;Skin;Carcinogen JAN 1993 OEL-JAPAN:TWA 0.3 mg/m3;Skin JAN 1993 OEL-THE NETHERLANDS:TWA 0.3 mg/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 0.3 mg/m3;Skin JAN 1993 OEL-RUSSIA:STEL 0.2 mg/m3;Skin JAN 1993 OEL-SWEDEN:TWA 0.3 mg/m3;STEL 0.9 mg/m3;Skin JAN 1993 OEL-SWITZERLAND:TWA 0.3 mg/m3;Skin;Carcinogen JAN 1993 OEL-UNITED KINGDOM:TWA 0.3 mg/m3;STEL 0.6 mg/m3;Skin JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO ACRYLAMIDE-air:10H CA TWA 0.03 mg/m3 (Sk) REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 03540 No. of Facilities: 442 (estimated) No. of Industries: 10 No. of Occupations: 24 No. of Employees: 7047 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 03540 No. of Facilities: 453 (estimated) No. of Industries: 19 No. of Occupations: 22 No. of Employees: 10651 (estimated) No. of Female Employees: 721 (estimated)
- 毒理学数据：
1.急性毒性[15]
LD50：150~180mg/kg（大鼠经口）
2.刺激性[16]
家兔经皮：500mg（24h），轻度刺激。
家兔经眼：100mg（24h），中度刺激。
3.亚急性与慢性毒性[17] 多次重复染毒，几乎全部动物发生周围神经损害，表现四肢肌肉无力、后肢严重瘫痪、肢体远端肌肉萎缩、感觉障碍及腱反射消失。
4.致敏性[18] 对皮肤有致敏作用。
致突变性 姐妹染色单体交换：大鼠经口600mg/kg（连续10d）。精子形态学改变：小鼠腹腔注射100mg/kg。
5.致畸性[19] 雌性小鼠受孕后6~17d，经口染毒540mg/kg，引发仔鼠肌肉骨骼系统发育畸形。
6.致癌性[20] IARC致癌性评论：G2A，可能人类致癌物。
7.其他[21] 大鼠经口最低中毒剂量（TDLo）：200mg/kg（孕7~16d），引起新生鼠生化和代谢改变。大鼠经口最低中毒剂量（TDLo）：544mg/kg（9周，雄性），引起精子、雄性生育指数改变和植入后死亡率增加。
- 生态数据：
1.生态毒性[22]
LC50：103~115mg/L（96h）（黑头呆鱼）；110mg/L（96h）（虹鳟鱼）；100mg/L（96h）（蓝鳃太阳鱼）；160mg/L（48h）（水蚤）
2.生物降解性 暂无资料
3.非生物降解性[23] 空气中，当羟基自由基浓度为5.00×105个/cm3时，降解半衰期为1.4d（理论）。
丙烯酰胺 MSDS
| 国标编号: | 61740 |
| ＣＡＳ: | 79-06-1 |
| 中文名称: | 丙烯酰胺 |
| 英文名称: | Acrylamide |
| 别 名: | |
| 分子式: | C3H5NO；CH2CHCONH2 |
| 分子量: | 71.08 |
| 熔 点: | 84.5℃ 沸点：125℃/3 |
| 密 度: | 相对密度(水=1)1.12； |
| 蒸汽压: | 0.21kPa(84.5℃) |
| 溶解性: | 溶于水、乙醇、乙醚、丙酮，不溶于苯 |
| 稳定性: | 稳定 |
| 外观与性状: | 白色结晶固体，无气味 |
| 危险标记: | 15(毒害品) |
| 用 途: | 用于制造水溶性聚合物即聚丙烯酰胺 |
2.对环境的影响:
一、健康危害
侵入途径：吸入、食入、经皮吸收。
健康危害：本品具神经毒作用。可引起疲嗜睡、手指麻木，位置性震颤，步态紊乱，肌肉萎缩，肌肉无力，手出汗脱屑以及接触性皮炎等。
二、毒理学资料及环境行为
毒性：中等毒类。
急性毒性：LD50 150～180mg/kg(大鼠经口)
刺激性：家兔经眼：5mg(24小时)，重度刺激。
亚急性和慢性毒性：大鼠经口食物中添加0.02%～0.04%本品，1～6个月，出现末梢神经，神经轴突、髓膜变性。
致突变性：姊妹染色单体交换：大鼠经口600mg/kg，10天(连续)。精子形态学改变：小鼠腹腔注射100mg/kg。
生殖毒性：大鼠经口最低中毒剂量(TDL0)：200mg/kg(孕7～16天)，引起新生鼠生化和代谢改变。大鼠经口最低中毒剂量(TDL0)：544mg/kg(9周，雄性)，引起精子、雄性生育指数改变和植入后死亡率增加。
致癌性：IARC致癌性评论：动物阳性。
危险特性：遇高热、明火或与氧化剂接触，有引起燃烧的危险。若遇高热，可能发生聚合反应，出现大量放热现象，引起容器破裂和爆炸事故。
燃烧(分解)产物：一氧化碳、二氧化碳。
3.现场应急监测方法:
4.实验室监测方法:
气相色谱法 《水质分析大全》 张宏陶等主编
气相色谱法《固体废弃物试验与分析评价手册》中国环境监测总站等译
色谱-质谱法 《水和废水标准检验法》第19版译文，江苏省环境监测中心
5.环境标准:
前苏联(1975)车间卫生标准 0.3mg/m3
中国(待颁布) 饮用水源水中有害物质的最高容许浓度 0.0005mg/L
6.应急处理处置方法:
一、泄漏应急处理
隔离泄漏污染区，周围设警告标志，建议应急处理人员戴好防毒面具，穿化学防护服。不要直接接触泄漏物，用洁清的铲子收集于干燥净洁有盖的容器中，运至废物处理场所。也可以用大量水冲洗，经稀释的洗水放入废水系统。如大量泄漏，收集回收或无害处理后废弃。
废弃物处置方法：用焚烧法。焚烧炉排出的氮氧化物通过洗涤器除去。
二、防护措施
呼吸系统防护：空气中浓度超标时，应该佩带防毒面具。紧急事态抢救或逃生时，佩带自给式呼吸器。
眼睛防护：必要时戴安全防护眼镜。
防护服：穿相应的防护服。
手防护：戴防化学品手套。
其它：工作现场禁止吸烟、进食和饮水。工作后，彻底清洗。单独存放被毒物污染的衣服，洗后再用。进行就业前和定期的体检。
三、急救措施
皮肤接触：脱去污染的衣着，用肥皂水及清水彻底冲洗。
眼睛接触：立即提起眼睑，用流动清水冲洗。
吸入：脱离现场至空气新鲜处。必要时进行人工呼吸。就医。
食入：误服者给饮大量温水，催吐。就医。
灭火方法：二氧化碳、干粉、砂土。
丙烯酰胺 分子结构与计算化学数据
分子结构数据
1、摩尔折射率：19.23
2、摩尔体积（cm3/mol）：73.9
3、等张比容（90.2K）：174.6
4、表面张力（dyne/cm）：31.0
5、极化率（10-24cm3）：7.62
计算化学数据
1、疏水参数计算参考值（XlogP）：-0.7
2、氢键供体数量：1
3、氢键受体数量：1
4、可旋转化学键数量：1
5、互变异构体数量：2
6、拓扑分子极性表面积（TPSA）：43.1
7、重原子数量：5
8、表面电荷：0
9、复杂度：57.9
10、同位素原子数量：0
11、确定原子立构中心数量：0
12、不确定原子立构中心数量：0
13、确定化学键立构中心数量：0
14、不确定化学键立构中心数量：0
15、共价键单元数量：1
丙烯酰胺 上游产品
丙烯酰胺 下游产品
推荐供应商
武汉吉鑫益邦生物科技有限公司
丙烯酰胺
- 联系人：周美玲
- 电 话：027-59768650
- 手 机：15629090339
- Cas号：79-06-1
- 包装：1kg,25kg,200kg,400kg,500kg
- 纯度：0-99%
- 价格：洽谈